Personalizing Therapy for Patients With CML

Michael J. Mauro, MD

Video Categories: CML

Dr. Mauro addresses the debate over selecting first line therapy with three approved agents available.
October 10, 2016

Immunotherapy’s Role in Treating Hormone Receptor–Positive Diseases

Dr Thomas Bachelot discusses the potential for incorporating immunotherapy into the treatment of patients with hormone receptor–positive diseases but notes that the current data are weak, and further studies are needed to get a better sense of the viability of this treatment option.

January 13, 2015

BCI and Adherence

Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the importance of using a clinically validated test such as the Breast Cancer IndexSM (BCI) and its impact on patient confidence in their treatment plan.